knowledge -WSS

knowledge

author：Wikipedia 2025-09-30 00:05:01 - browse：518

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb said that it would purchase Mirati Therapeutics, maker of the cancer drug Krazati, for $4.8 billion in cash in a deal that shows the continued interest of large pharmaceutical firms in relatively small “bolt-on” acquisitions.

Bristol said that it would pay $58.00 per share for Mirati, and would hold another $12.00 per share, or a total of $1 billion, to be paid if one of two different applications for an additional use for Krazati is approved within seven years after the merger closes.

Chris Boerner, Bristol’s chief operating officer and CEO-elect, said in a statement that Mirati had several cancer drugs in development that could deliver sales in the latter half of the decade and beyond, when investors worry that Bristol will need new products to sustain its growth.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： WATCH: Why do fingernails fall off when they're damaged?

WSS

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

CDC concerned about possible undetected monkeypox spread in U.K.

Weight bias in eating disorder treatment complicated by new weight loss drugs

FDA approves Recor Medical high blood pressure device

Death of patient in Alzheimer’s trial raises question of possible risks

Ambulance rides for just $100? Advisers want major billing fixes

hotspot

knowledge

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Senate panel clears PBM, hopsital reforms

In Memoriam: Notable people who died in 2023

A clever new way to fix Medicaid and graduate medical education

Peter Hotez and the public health issue of online harassment

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Affirmative action in medical school literally saved lives

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Heart attack and stroke risk calculators need revising

Medicare will require more price transparency from hospitals

hotspot

The battle over the Brookhaven Landfill on Long Island

Excited delirium, Elijah McClain, and emergency physicians

Biotech incubator Curie.Bio graduates its first startup

Why drug prescriptions should include diagnoses

Weight bias in eating disorder treatment complicated by new weight loss drugs

Medicare will require more price transparency from hospitals

leisure time

leisure time

hotspot

leisure time